RNS Number : 4345V
Legal & General UCITS ETF PLC
07 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
06/08/2020 |
IE00BFXR5Q31 |
12799267 |
USD |
162088527.32 |
12.664 |
| L&G UK Equity UCITS ETF |
06/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10694055.70 |
8.912 |
| L&G Global Equity UCITS ETF |
06/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34933731.26 |
12.046 |
| L&G Japan Equity UCITS ETF |
06/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
118674448.32 |
10.610 |
| L&G Europe ex UK Equity UCITS ETF |
06/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
100935354.35 |
10.783 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
06/08/2020 |
IE00BFXR5W90 |
5181427 |
USD |
56029134.25 |
10.813 |
| L&G Clean Water UCITS ETF |
06/08/2020 |
IE00BK5BC891 |
1500000 |
USD |
16818195.55 |
11.212 |
| L&G Artificial Intelligence UCITS ETF |
06/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
112392663.12 |
14.145 |
| L&G Healthcare Innovation UCITS ETF |
06/08/2020 |
IE00BK5BC677 |
3000000 |
USD |
42515007.06 |
14.172 |
| L&G Pharma Breakthrough UCITS ETF |
06/08/2020 |
IE00BF0H7608 |
2150000 |
USD |
26645193.89 |
12.393 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
06/08/2020 |
IE00BKLTRN76 |
9600000 |
EUR |
97884029.89 |
10.196 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
06/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
661263495.84 |
11.441 |
| L&G Battery Value-Chain UCITS ETF |
06/08/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
141938744.88 |
10.753 |
| L&G Ecommerce Logistics UCITS ETF |
06/08/2020 |
IE00BF0M6N54 |
9600000 |
USD |
112846671.15 |
11.755 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
06/08/2020 |
IE00BMW3QX54 |
46630616 |
USD |
873747075.42 |
18.738 |
| L&G Cyber Security UCITS ETF |
06/08/2020 |
IE00BYPLS672 |
82711776 |
USD |
1700686281.39 |
20.562 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVDZGGRZVMGGZZ
